383
Views
7
CrossRef citations to date
0
Altmetric
Articles

Women veterans and menopause: Knowledge and preferences

, PhD, , MSW, , MD, , MA, MPH, , MD, , MD, JD & , MD show all
Pages 898-914 | Received 08 Apr 2017, Accepted 20 Jul 2017, Published online: 05 Sep 2017

References

  • American College of Obstetricians and Gynecologists. 2014. ACOG practice bulletin no. 141: Management of menopausal symptoms. Obstetrics and Gynecology 123 (1):202–16. doi:10.1097/01.aog.0000441353.20693.78.
  • Avis, N. E., S. L. Crawford, G. Greendale, J. T. Bromberger, S. A. Everson-Rose, E. B. Gold, R. Hess, H. Joffe, H. M. Kravitz, P. G. Tepper, and R. C. Thurston. 2015. Study of women’s health across the nation. JAMA Internal Medicine 175 (4, April):531–39. doi:10.1001/jamainternmed.2014.8063.
  • Corbin, J., and S. L. Strauss. 2007. Basics of qualitative research: Grounded theory procedures and techniques, 3rd ed. London, UK: Sage.
  • Frayne, S. M., C. S. Phibbs, S. A. Friedman, E. Berg, L. Ananth, S. Iqbal, P. M. Hayes, and L. Herrera. 2010. Sourcebook: Women veterans in the veterans health administration. Volume 1. Sociodemographic characteristics and use of VHA care. Washington, DC: Women’s Health Evaluation Initiative, Women Veterans Health Strategic Health Care Group, Veterans Health Administration, Department of Veterans Affairs.
  • Frayne, S. M., C. S. Phibbs, S. A. Friedman, F. Saechao, E. Berg, V. Balasubramanian, X. Bi, S. Iqbal, K. Mattocks, S. Haskell, L. Zephyrin, A. Torgal, A. Whitehead, and P. M. Hayes. 2012. Sourcebook: Women veterans in the veterans health administration. Volume 2. Sociodemographics and use of VHA and Non-VA Care (Fee). Washington, DC: Women’s Health Evaluation Initiative, Women’s Health Services, Veterans Health Administration, Department of Veterans Affairs.
  • Freeman, E. W., M. D. Sammel, H. Lin, and D. B. Nelson. 2006. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Archives of General Psychiatry 63 (4):375–82. doi:10.1001/archpsyc.63.4.375.
  • Freeman, E. W., M. D. Sammel, and R. J. Sanders. 2014. Risk of long-term hot flashes after natural menopause: Evidence from the penn ovarian aging study cohort. Menopause 21 (9):924–32. doi:10.1097/gme.0000000000000196.
  • Gallicchio, L., M. K. Whiteman, D. Tomic, K. P. Miller, P. Langenberg, and J. A. Flaws. 2006. Type of menopause, patterns of hormone therapy use, and hot flashes. Fertility and Sterility 85 (5):1432–40. doi:10.1016/j.fertnstert.2005.10.033.
  • Gerber, M. R., M. W. King, S. L. Pineles, S. Wiltsey-Stirman, B. Bean-Mayberry, S. J. Japuntich, and S. G. Haskell. 2015. Hormone therapy use in women veterans accessing veterans health administration care: A national cross-sectional study. Journal of General Internal Medicine 30 (2):169–75. doi:10.1007/s11606-014-3073-9.
  • Glaser, B. G., and A. L. Strauss. 1967. Discovery of grounded theory: Strategies for qualitative research. New York: Aldine De Gruyter.
  • Hlatky, M. A., D. Boothroyd, E. Vittinghoff, P. Sharp, and M. A. Whooley. 2002. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: Results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. Jama 287 (5):591–97. doi:10.1001/jama.287.5.591.
  • Katon, J. G., K. E. Gray, M. R. Gerber, L. B. Harrington, N. F. Woods, J. C. Weitlauf, B. Bean-Mayberry, K. M. Goldstein, J. R. Hunt, W. J. Katon, S. G. Haskell, S. J. McCutcheon, M. L. Gass, C. J. Gibson, and L. C. Zephyrin. 2016. Vasomotor symptoms and quality of life among veteran and non-veteran postmenopausal women. Gerontologist 56 (Suppl 1):S40–53. doi:10.1093/geront/gnv104.
  • Katon, J. G., K. J. Hoggatt, V. Balasubramanian, F. S. Saechao, S. M. Frayne, K. M. Mattocks, K. B. Feibus, I. V. Galvan, R. Hickman, P. M. Hayes, S. G. Haskell, E. M. Yano, C. S. Phibbs, and L. C. Zephyrin. 2015. Reproductive health diagnoses of women veterans using department of veterans affairs health care. Medical Care 53 (4 Suppl 1):S63–7. doi:10.1097/mlr.0000000000000295.
  • Kitto, S. C., J. Chesters, and C. Grbich. 2008. Quality in qualitative research. The Medical Journal of Australia 188 (4):243–46.
  • Kleinman, N. L., N. J. Rohrbacker, A. G. Bushmakin, J. Whiteley, W. D. Lynch, and S. N. Shah. 2013. Direct and indirect costs of women diagnosed with menopause symptoms. Journal of Occupational and Environmental Medicine 55 (4):465–70. doi:10.1097/JOM.0b013e3182820515.
  • Manson, J. E., R. T. Chlebowski, M. L. Stefanick, A. K. Aragaki, J. E. Rossouw, R. L. Prentice, G. Anderson, B. V. Howard, C. A. Thomson, A. Z. LaCroix, J. Wactawski-Wende, R. D. Jackson, M. Limacher, K. L. Margolis, S. Wassertheil-Smoller, S. A. Beresford, J. A. Cauley, C. B. Eaton, M. Gass, J. Hsia, K. C. Johnson, C. Kooperberg, L. H. Kuller, C. E. Lewis, S. Liu, L. W. Martin, J. K. Ockene, M. J. O’Sullivan, L. H. Powell, M. S. Simon, L. Van Horn, M. Z. Vitolins, and R. B. Wallace. 2013. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health initiative randomized trials. Jama 310 (13):1353–68. doi:10.1001/jama.2013.278040.
  • Mays, N., and C. Pope. 2000. Qualitative research in health care. Assessing quality in qualitative research. Bmj 320 (7226):50–52. doi:10.1136/bmj.320.7226.50.
  • National Center for Veterans Analysis and Statistics. 2016. Age/gender population table. http://www.va.gov/vetdata/Veteran_Population.asp (accessed March 28, 2016).
  • North American Menopause Society. 2012. The 2012 hormone therapy position statement of: The North American menopause society. Menopause 19 (3):257–71. doi:10.1097/gme.0b013e31824b970a.
  • North American Menopause Society. 2015. Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American menopause society. Menopause 22 (11):1155–72; quiz 1173–4. doi:10.1097/gme.0000000000000546.
  • Pinkerton, J. V., H. Joffe, K. Kazempour, H. Mekonnen, S. Bhaskar, and J. Lippman. 2015. Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause. Menopause 22 (1):50–58. doi:10.1097/gme.0000000000000311.
  • Rossouw, J. E., G. L. Anderson, R. L. Prentice, A. Z. LaCroix, C. Kooperberg, M. L. Stefanick, R. D. Jackson, S. A. Beresford, B. V. Howard, K. C. Johnson, J. M. Kotchen, and J. Ockene. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women’s health initiative randomized controlled trial. Jama 288 (3):321–33. doi:10.1001/jama.288.3.321.
  • Santen, R. J., D. C. Allred, S. P. Ardoin, D. F. Archer, N. Boyd, G. D. Braunstein, H. G. Burger, G. A. Colditz, S. R. Davis, M. Gambacciani, B. A. Gower, V. W. Henderson, W. N. Jarjour, R. H. Karas, M. Kleerekoper, R. A. Lobo, J. E. Manson, J. Marsden, K. A. Martin, L. Martin, J. V. Pinkerton, D. R. Rubinow, H. Teede, D. M. Thiboutot, and W. H. Utian. 2010. Postmenopausal hormone therapy: An endocrine society scientific statement. The Journal of Clinical Endocrinology and Metabolism 95 (7 Suppl 1):s1–s66. doi:10.1210/jc.2009-2509.
  • Santoro, N., C. N. Epperson, and S. B. Mathews. 2015. Menopausal symptoms and their management. Endocrinology and Metabolism Clinics of North America 44 (3):497–515. doi:10.1016/j.ecl.2015.05.001.
  • Sarrel, P., D. Portman, P. Lefebvre, M. H. Lafeuille, A. M. Grittner, J. Fortier, J. Gravel, M. S. Duh, and P. M. Aupperle. 2015. Incremental direct and indirect costs of untreated vasomotor symptoms. Menopause 22 (3):260–66. doi:10.1097/gme.0000000000000320.
  • Shifren, J. L., and I. Schiff. 2010. Role of hormone therapy in the management of menopause. Obstetrics and Gynecology 115 (4):839–55. doi:10.1097/AOG.0b013e3181d41191.
  • Thomas, D. R. 2006. A general inductive approach for analyzing qualitative evaluation data. American Journal of Evaluation 27 (2):237–46. doi:10.1177/1098214005283748.
  • Thurston, R. C., S. R. El Khoudary, P. G. Tepper, E. A. Jackson, H. Joffe, H. Y. Chen, and K. A. Matthews. 2016. Trajectories of vasomotor symptoms and carotid intima media thickness in the study of women’s health across the nation. Stroke 47 (1):12–17. doi:10.1161/strokeaha.115.010600.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.